Endogene.Bio | Building a legacy in female health

Maria Teresa is a biophysicist with extensive biotech and pharma experience. She worked as a Fertility Portfolio Expansion Managerand In-House Consultant at Merck KGaA and completed a PhD in Medical Devices. She has a Masters in Bioscience Enterprise from the University of Cambridge, where she currently lectures on Female Health.

Dr. MT Pérez Zaballos

CEO-Founder

Cristina completed her PhD at Institut Pasteur, researching accelerated aging in Cockayne Syndrome, after earning a Master’s in Molecular Biomedicine from the Autonomous University of Madrid. She has 6 years of research experience in areas like immunology, endometriosis, and menstrual blood and leads the R&D development of EndoGene.Bio.

Dr. C Fernández Molina

Head of Science & Ops- Late Co-Founder

Ioanna has over 16 years of research experience in cancer biology, cardiovascular, and autoimmune diseases. She spent the last few years at NYU Medical School, completing her postdoctoral studies in Immunology, and brings expertise in advanced experimental techniques and project management to the team.

Ioanna Tiniakou

Sr. Immunologist

Sophie has 8 years of experience at a leading in vitro diagnostics and theranostics company, where she focused on measuring the effectiveness of biotherapies for autoimmune diseases and cancer, contributing to the development of personalized treatments. She brings her expertise in diagnostic technologies and personalized medicine to the team.

Sophie Ribeiro

Sr. Lab Specialist

Raúl is a bioinformatician with over 6years of experience, specializing in women's health research. At Igenomix, he developed scRNA-seq pipelines, created the first atlas of Asherman's syndrome, and investigated the microbiome's role in endometriosis. He also identified potential drug candidates for SARS-CoV-2 during the pandemic. Raúl brings key expertise in transcriptomics and data analysis to EndoGene.

Raúl Pérez Moraga

Bioinformatics Scientist

Cemsel holds a PhD from the University of Manchester, where she specialized in using genomics for risk prediction and targeted prevention of endometrial cancer. With experience from institutions like the Wellcome Trust Sanger Institute and the University of Oxford, she has researched novel biomarkers and risk prediction for women’s health, including studies on menstrual blood, endometriosis, and endometrial cancer using multi-omics methods.

Dr. C Bafligil Suomi

Senior Bioinformatics Scientist

Laura holds a double degree in International Studies and Law from Universidad Carlos III de Madrid. She plays a key role in managing and optimizing daily operations and serves as the Chief Finance Officer at the non-profit Journal of Young Investigators.

Laura Plaza Arroyo

Corporate Ops

Teresa is a seasoned consultant and manager in medical and clinical operations with 12 years of experience in clinical development. She holds a PhD in Biomedical Sciences and has held key roles at Janssen Pharmaceutical, BioScience GmbH, and Gyala Therapeutics. She also contributes as a Professor in the Advanced Therapies MBA at ESAME Pharmaceutical Business School.

Dr. Teresa Galera Monge

Clinical Manager

Roberto earned his PhD at Institut Pasteur, where he studied cellular structures linked to cancer and neurodegenerative conditions. With 6 years of research experience at top institutions, he brings strong skills in research and communication to the team.

Dr. R Notario Manzano

R&D Project Manager

Sarah completed her PhD at the University of Warwick, focusing on metabolites secreted by endometrial stromal cells to identify biomarkers for reproductive disorders. With over 6 years of experience, including work at the Singapore-MIT Alliance for Research & Technology on autoantibodies in endometriosis, she brings expertise in key areas and techniques our research projects.

Meet the team.